Nurtec ODT לטיפול ומניעת התקפי מיגרנה ¹

REFERENCES:
1. Nurtec ODT approved prescribing information.
2. Croop R, Goadsby PJ, Stock DA, et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019;394(10200):737-745.
3. Croop R, Lipton RB, Kudrow D, et al. Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo controlled trial. Lancet. 2021;397(10268):51-60.
4. Wilbanks et al. Migraine in Adult Primary Care, The Journal for Nurse Practitioners, Volume 18, Issue 4, 2022, Pages 366-369